Eisai Co., Ltd. (TYO:4523)
Japan · Delayed Price · Currency is JPY 5,031.00
+8.00 (0.16%)
At close: Nov 26, 2025
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
73.68M JPY
Profits / Employee
4.52M JPY
Market Cap
1.38T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10,917 | -150 | -1.36% |
| Mar 31, 2024 | 11,067 | -9 | -0.08% |
| Mar 31, 2023 | 11,076 | -246 | -2.17% |
| Mar 31, 2022 | 11,322 | 85 | 0.76% |
| Mar 31, 2021 | 11,237 | 239 | 2.17% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Olympus | 29,297 |
| Daiichi Sankyo Company | 19,765 |
| M3, Inc. | 15,360 |
| Astellas Pharma | 13,643 |
| Kyowa Kirin | 5,669 |
Eisai News
- 9 days ago - Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference - PRNewsWire
- 21 days ago - Q2 2026 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 21 days ago - Eisai Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 22 days ago - Eisai Co., Ltd. (ESAIY) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Eisai reports H2 results - Seeking Alpha
- 22 days ago - Eisai H1 Profit Rises - Nasdaq
- 23 days ago - Full Year 2025 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 4 weeks ago - Merck (MRK) and Eisai Conclude Keytruda-Lenvima Trial for Liver Cancer - GuruFocus